Theratechnologies (TSE:TH) Stock Price Crosses Above Fifty Day Moving Average – Here’s What Happened

Theratechnologies Inc. (TSE:THGet Free Report)’s share price passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of C$1.72 and traded as high as C$1.77. Theratechnologies shares last traded at C$1.73, with a volume of 12,580 shares changing hands.

Theratechnologies Stock Performance

The company has a quick ratio of 0.64, a current ratio of 1.10 and a debt-to-equity ratio of 562.07. The company has a market capitalization of C$79.55 million, a PE ratio of -9.61, a PEG ratio of -8.50 and a beta of 1.73. The stock’s fifty day simple moving average is C$1.72 and its 200-day simple moving average is C$1.79.

Theratechnologies (TSE:THGet Free Report) last issued its quarterly earnings data on Thursday, October 10th. The company reported C$0.09 earnings per share for the quarter. Theratechnologies had a negative net margin of 8.47% and a negative return on equity of 1,116.86%. The business had revenue of C$30.96 million during the quarter. On average, research analysts predict that Theratechnologies Inc. will post 0.0298643 earnings per share for the current fiscal year.

About Theratechnologies

(Get Free Report)

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.

Read More

Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.